Silverstein Dream Foundation’s 5th Annual Hamptons Garden Gala Advances Diabetes Research

The Hamptons social calendar turned its attention to a deeply personal cause on August 15, as Patricia and Roger Silverstein welcomed guests to their Water Mill estate for the 5th Annual Hamptons Garden Gala. Hosted by the Silverstein Dream Foundation, the event brought together leading philanthropists, community figures, and supporters of the Diabetes Research Institute Foundation (DRIF) in an evening designed to raise both awareness and critical funding for diabetes research.

The night began with a cocktail reception, where guests enjoyed sweeping views of the Silverstein property while reconnecting with friends and fellow advocates. As twilight set in, attendees gathered for a seated dinner, followed by a program of heartfelt remarks from DRIF ambassadors and supporters. Their stories underscored the urgency of advancing research and the impact of the Foundation’s mission.

A spirited live auction, engaging entertainment, and dancing carried the evening forward, creating a warm and intimate atmosphere that balanced celebration with purpose. The event served not only as a major philanthropic milestone for the summer season but also as a reminder of the power of community-driven initiatives in tackling chronic health challenges.

The gala drew a distinguished guest list, including Roger Silverstein, Patricia Silverstein, Brian Packin, Carrie Packin, Nitin Gambhir, Elena Ulansky, Peter Thomas-Roth, Jean Shafiroff, Joseph Donovan, James Brynes, Noreen Donovan, Karen Ressler, Scott Ressler, Rebecca Swanson, Dave Swanson, Ni Ricordi, Sugie Hong Bruttomesso, Devra Miller, Regina Mukhtarova, and Sarrah Rose.

Founded with the goal of creating lasting change in the fight against diabetes, the Silverstein Dream Foundation supports research and addresses the chronic conditions associated with the disease and its inflammatory effects.

Its work is anchored in three core pillars:

• Supporting Academic Research – Funding groundbreaking studies and clinical advancements.

• Implementing Diabetes Prevention Programs – Promoting awareness, education, and early intervention.

• Strategic Investments in Early-Stage Companies – Backing innovative solutions and technologies poised to transform patient care.

Through these combined efforts, the Foundation seeks to accelerate progress toward a cure while improving the quality of life for those living with diabetes.